Aptamer Sciences Inc (KOSDAQ:291650)
South Korea · Delayed Price · Currency is KRW 1,941.00
+1.00 (0.05%)
At close: Apr 3, 2026
Aptamer Sciences Market Cap
Aptamer Sciences has a market cap or net worth of 78.14 billion as of April 2, 2026. Its market cap has increased by 184.81% in one year.
Market Cap
78.14B
Enterprise Value
68.67B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,941.00
Market Cap Chart
Since September 16, 2020, Aptamer Sciences's market cap has decreased from 234.93B to 78.14B, a decrease of -66.74%. That is a compound annual growth rate of -18.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 78.14B | 156.07% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cell Biotech | 97.39B |
| Progen | 91.64B |
| CTCBIO | 90.14B |
| Choong Ang Vaccine Laboratory | 85.79B |
| Shaperon | 76.62B |
| PanGen Biotech | 70.84B |
| Ark Solutions | 68.91B |
| Naturalendo Tech | 65.20B |